{"nct_id":"NCT04732871","title":"Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2023-12","start_date":"2021-02-15","start_date_type":"ACTUAL","primary_completion_date":"2022-06-06","primary_completion_date_type":"ACTUAL","completion_date":"2026-05-25","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}